| Predicate |
Object |
| contentType |
Evaluation Study|Journal Article|Review |
| issn |
1748-717X |
| issueIdentifier |
1 |
| pageRange |
2- |
| publicationName |
Radiation oncology (London, England) |
| startingPage |
2 |
| bibliographicCitation |
Beal K, Abrey LE, Gutin PH. Antiangiogenic agents in the treatment of recurrent or newly diagnosed glioblastoma: Analysis of single-agent and combined modality approaches. Radiation Oncology. 2011 Jan 07;6(1):2. doi: 10.1186/1748-717x-6-2. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_292621c17b1b316fc4655bd75136a2c6
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a1361cc400a38dc33316e95bc969fd1f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0bd6d1fbdfa593ea9d54195d6dc81669 |
| date |
2011-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/PMC3025871
https://doi.org/10.1186/1748-717x-6-2
https://pubmed.ncbi.nlm.nih.gov/21214925 |
| isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/32756
https://portal.issn.org/resource/ISSN/1748-717X |
| language |
English |
| source |
https://www.crossref.org/
https://scigraph.springernature.com/
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
Antiangiogenic agents in the treatment of recurrent or newly diagnosed glioblastoma: Analysis of single-agent and combined modality approaches |
| discusses |
http://id.nlm.nih.gov/mesh/M0001357
http://id.nlm.nih.gov/mesh/M0328153
http://id.nlm.nih.gov/mesh/M0443627
http://id.nlm.nih.gov/mesh/M0556300 |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176873
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5394
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60838
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25102847
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7838 |